JOHN BARDI — Lobbyist Profile | Poliscope

JOHN BARDI

Filings

Clients

Firms

Years active

2016–2017

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
OTSUKA AMERICA PHARMACEUTICAL, INC.	11	2016–2017

Lobbying firms

Firm	Filings	Years
OTSUKA AMERICA PHARMACEUTICAL, INC.	11	2016–2017

Bills explicitly cited in this lobbyist’s assigned issues (20)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1245

Affordable and Safe Prescription Drug Importation Act

Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.

Open original LDA filing ↗

Cited source text

S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA); Veterans Issues

H.R. 1245

Affordable and Safe Prescription Drug Importation Act

Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (11)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2017 · third_quarter · Q3

Firm income: —Client expense: $170,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2017 · second_quarter · Q2

Firm income: —

Source: Senate LDA

Show 7 more original filings

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · second_quarter · 2A

Firm income: —Client expense: $220,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · fourth_quarter · Q4

Firm income: —Client expense: $80,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

H.R.34 - 21st Century Cures Act.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · third_quarter · 3A

Firm income: —Client expense: $240,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · second_quarter · Q2

Firm income: —Client expense: $220,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · first_quarter · Q1

Firm income: —Client expense: $410,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.1945: Mental Health Reform Act of 2015, S. 1893: Mental Health Awareness and Improvement Act of 2015, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.

2016 · first_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

GOV

Government Issues

Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2

MMM

Medicare/Medicaid

Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2

MED

Medical/Disease Research/Clinical Labs

Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2